scholarly journals Galactosialidosis Type IIb with Bilateral Macular Cherry-Red Spots but Mild Dysfunction

2020 ◽  
Vol 11 (2) ◽  
pp. 306-314
Author(s):  
Hanon Fukuyo ◽  
Yuji Inoue ◽  
Hidenori Takahashi ◽  
Yu Hatano ◽  
Toko Shibuya ◽  
...  

Galactosialidosis is a rare metabolic disorder resulting from mutations in the CTSA gene. Few studies have reported on the ocular findings of galactosialidosis type IIb in detail. We report on a case of galactosialidosis, the diagnosis of which was suggested by bilateral macular cherry-red spots, which is an indication of lysosomal storage disease. In this case, retinal and systemic dysfunctions were mild. Genetic studies revealed an abnormality of relevant protective proteins, and thus a definitive diagnosis was made. The patient was a 35-year-old man who had blurred vision from young age, but he did not seek any therapy due to good visual acuity. He visited a local clinic after the blurred vision in the left eye worsened and was referred to us for bilateral macular cherry-red spots. He had no family history of note. We observed fine grayish-white deposits in the corneal stroma and fine opacity of the lens. Optical coherence tomography showed a hyperreflective region and a thick bilateral retinal ganglion cell layer. Goldmann perimetry showed focal loss of sensitivity. There was almost no functional decline noted on multifocal electroretinography. Lysosomal storage disease was suspected due to corneal clouding and macular cherry-red spots, and so further evaluation was performed. Though neurological abnormality was mild, we made a diagnosis of galactosialidosis because of decreased activity of β-galactosidase and sialidase. Genetic studies revealed an abnormality of relevant protective proteins. Since the onset was later in life and clinical symptoms were mild, we expect that the ophthalmological findings will remain stable. Long-term observation is necessary for this case.

2008 ◽  
Vol 47 (06) ◽  
pp. 239-247 ◽  
Author(s):  
S. Kohlfürst ◽  
H. J. Gallowitsch ◽  
E. Kresnik ◽  
P. Lind ◽  
A. B. Mehta ◽  
...  

SummaryGaucher disease is the most prevalent inherited, lysosomal storage disease and is caused by deficient activity of the enzyme β-glucocerebrosidase. Bone and bone marrow alterations are frequent in the most prevalent non-neuronopathic form of Gaucher disease. Imaging of bone manifestations in Gaucher disease is performed by a variety of imaging methods, conventional X-ray and MRI as the most frequently and most important ones. However, different modalities of scintigraphic imaging have also been used. This article gives an overview on scintigraphic imaging with respect to bone manifestations in Gaucher disease discussing the advantages and limitations of scintigraphic imaging in comparison to other imaging methods.


Radiology ◽  
1983 ◽  
Vol 149 (2) ◽  
pp. 463-467 ◽  
Author(s):  
A Daneman ◽  
D Stringer ◽  
B J Reilly

2015 ◽  
Vol 7 (2) ◽  
pp. 158-174 ◽  
Author(s):  
Gennaro Napolitano ◽  
Jennifer L Johnson ◽  
Jing He ◽  
Celine J Rocca ◽  
Jlenia Monfregola ◽  
...  

2007 ◽  
Vol 49 (7) ◽  
pp. 571-578 ◽  
Author(s):  
Taina Autti ◽  
Raimo Joensuu ◽  
Laura Åberg

1994 ◽  
Vol 87 (6) ◽  
pp. 594-597 ◽  
Author(s):  
J. Alroy ◽  
Inna Lomakina ◽  
M. Castagnaro ◽  
E. Skutelsky

1990 ◽  
Vol 81 (4) ◽  
pp. 245-249 ◽  
Author(s):  
D. J. Prieur ◽  
A. J. Ahern-Rindell ◽  
R. D. Murnane ◽  
R. W. Wright ◽  
S. M. Parish

Sign in / Sign up

Export Citation Format

Share Document